Abstract
We have previously reported a strong correlation between poor prognosis in childhood neuroblastoma (NB) patients and high-level expression of the transmembrane efflux pump, Multidrug Resistance-associated Protein (MRP1), in NB tumour tissue. In this study, we inhibited the endogenous expression of MRP1 in 2 different NB tumour cell lines by stably transfecting an MRP1 antisense expression vector (MRP-AS). Compared with control cells, MRP-AS transfectant cells demonstrated a higher proportion of dead and morphologically apoptotic cells, spontaneous neuritogenesis, and, increased synaptophysin and neurofilament expression. Bcl-2 protein expression was markedly reduced in MRP-AS cells compared to controls. Conversely, we found that the same NB tumour cell line overexpressing the full-length MRP1 cDNA in sense orientation (MRP-S) demonstrated resistance to the neuritogenic effect of the differentiating agent, all-trans-retinoic acid. Taken together, the results suggest that the level of MRP1 expression in NB tumour cells may influence the capacity of NB cells for spontaneous regression in vivo through cell differentiation and death. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aggarwal S and Gupta S (1998) A possible role of multidrug resistance-associated protein (MRP) in the secretion of basic fibroblast growth factor by osteosarcoma cell line (MG-63). Int J Oncol 13: 1331–1334
Bader P, Schilling F, Schlaud M, Girgert R, Handgertinger R, Klingebiel T, Treuner J, Liu C, Niethammer D and Beck JF (1999) Expression of multidrug resistance associated genes in neuroblastomas. Oncology Rep 6: 1143–1146
Beckwith JB and Perrin EV (1963) In situ neuroblastoma. Am J Path 43: 1089–1104
Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD (1994) Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54: 5036–5040
Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159
Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650–1654
Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG (1994) Pharmacological characterisation of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902–5910
Davies AM (1997) Neurotrophin switching: where does it stand?. Curr Opin Neurobiol 7: 110–118
Deeley RG and Cole SPC (1997) Function, evolution and structure of multidrug resistance protein (MRP). Semin Cancer Biol 8: 193–204
Evans AE, Gerson J and Schnaufer L (1976) Spontaneous regression of neuroblastoma. Natl Cancer Inst Mongr 44: 49–54
Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC and Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases to natural product drugs. Cancer Res 54: 357–361
Gupta S, Aggarwal S and Nakamura S (1998) A possible role of multidrug resistance-associated protein (MRP) in basic fibroblast growth factor secretion by AIDS-associated Kaposi’s sarcoma cells: a survival molecule?. J Clin Immunol 18: 256–263
Haber M, Reed C, Kavallaris M, Norris MD and Stewart BS (1989) Resistance to drugs associated with the multidrug resistance phenotype following selection with high concentration methotrexate. J Natl Cancer Inst 81: 1250–1254
Haber M, Madafiglio J, Bordow SB, Gilbert J, Cheung B, Marshall GM and Norris MD (1994) Expression of retinoic acid-responsive genes in primary neuroblastomas. Prog Clin Biol Res 385: 245–251
Hoehner JC, Hedborg F, Wiklund HJ, Olsen L and Pahlman S (1995) Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int J Cancer 62: 19–24
Jahn R, Schiebler W, Ouimet C and Greengard P (1985) A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA 82: 4137–4141
Johnstone RW, Cretney E and Smyth MJ (1999) P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93: 1075–1085
Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 3: 614–628
Lock RB and Stribinskiene L (1996) Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56: 4006–4012
Lorico A, Rappa G, Finch RA, Yang D, Flavell RA and Sartorelli AC (1997) Disruption of the murine MRP gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res 57: 5238–5242
Marshall GM, Cheung B, Stacey KP, Camacho ML, Simpson AM, Kwan E, Smith S, Haber M and Norris MD (1995) Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Oncogene 11: 485–491
Matsunaga T, Shirasawa H, Hishiki T, Enomoto H, Kouchi K, Ohtsuka Y, Iwai J, Yoshida H, Tanabe M, Kobayashi S, Asano T, Etoh T, Nishi Y and Ohnuma N (1998) Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behaviour. Jpn J Cancer Res 89: 1276–1283
Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL and Haber M (1996) Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 334: 231–238
Robinson LJ, Roberts WK, Ling TT, Lamming D, Sternberg SS and Roepe PD (1997) Human MDR1 protein overexpression delays apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36: 11169–11178
Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB and Misugi K (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73: 405–416
Smyth MJ, Krasovskis E, Sutton VR and Johnstone RW (1998) The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA 95: 7024–7029
Wijnholds J, Evers R, van Leusden MR, Mol CA, Zaman GJ, Mayer U, Beijnen JH, van der Valk M, Krimpenfort P and Borst P (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Med 3: 1275–1279
Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Leupker R, Byrne T, Weitzman S, Bunin G and Lemieux B (1996) A population-based study of the usefulness of screening for neuroblastoma. Lancet 348: 1682–1687
Author information
Authors and Affiliations
Additional information
These authors contributed equally to this work.
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Peaston, A., Gardaneh, M., Franco, A. et al. MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells. Br J Cancer 85, 1564–1571 (2001). https://doi.org/10.1054/bjoc.2001.2144
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2144
Keywords
This article is cited by
-
Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma
Journal of Nanobiotechnology (2018)
-
ABC transporters in cancer: more than just drug efflux pumps
Nature Reviews Cancer (2010)
-
MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma
Oncogene (2004)